RLPC: Patheon readies $1.35B acq. loan for DSM Pharma combination
November 20, 2013 at 11:42 AM EST
NEW YORK, Nov 20 (Reuters) - Toronto-based drug maker Patheon Inc will launch in January $1.35 billion in acquisition financing to fund a transaction that will combine the company with the pharmaceuticals unit of Dutch food and chemicals group Royal DSM, sources told Thomson Reuters LPC Wednesday.
